Veracyte, Inc. VCYT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 64.62% | 2,701.02% | 307.36% | 704.79% | 26.28% |
| Total Depreciation and Amortization | 13.54% | -11.86% | 1.27% | -15.27% | -10.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.05% | -48.69% | 71.74% | -96.13% | 76.29% |
| Change in Net Operating Assets | -73.17% | -23.63% | 19.14% | 242.43% | 4,991.21% |
| Cash from Operations | -10.05% | 36.37% | 556.75% | 114.41% | 49.37% |
| Capital Expenditure | 16.40% | -122.32% | -62.84% | 8.72% | -24.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -68.56% | -1,106.21% | -150.00% | 102.39% | -- |
| Cash from Investing | -388.99% | -5,946.88% | -146.94% | 89.97% | 2,252.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -42.58% | 364.88% | -7.82% | 7.54% | -53.56% |
| Repurchase of Common Stock | -35.18% | -80.42% | 0.92% | -11.76% | -29.08% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -116.09% | 831.27% | -2.24% | 96.70% | -71.07% |
| Foreign Exchange rate Adjustments | -130.00% | -104.54% | -178.38% | 102.99% | -58.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -203.81% | 9.00% | -88.08% | 236.17% | 151.75% |